Gimsilumab

DB15280Investigational

Gimsilumab is under investigation in clinical trial NCT01357759 (Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects).

Mechanism: Pharmacologically active on Granulocyte-macrophage colony-stimulating factor
Curator reviewed
Code names: MORAB-022

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gimsilumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.